Mohamad Makhzoumi Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity

GLUE Quotes by TradingView

Mohamad Makhzoumi Transaction History

Date Transaction Value Shares Traded Form
Jun 28 2021
BUY
Open market or private purchase
$19,950,000 $19.0 p/Share
1,050,000
Jun 28 2021
BUY
Conversion of derivative security
-
6,642,298

Also insider at

EAR
Eargo, Inc. Healthcare
> 10% Shareholder
RGLS
Regulus Therapeutics Inc. Healthcare
> 10% Shareholder
MRKR
Marker Therapeutics, Inc. Healthcare
> 10% Shareholder
DM
Desktop Metal, Inc. Technology
> 10% Shareholder
BHG
Bright Health Group Inc. Healthcare
HOOD
Robinhood Markets, Inc. Technology
Director
TRVI
Trevi Therapeutics, Inc. Healthcare
> 10% Shareholder
MTCR
Metacrine, Inc. Healthcare
> 10% Shareholder
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
> 10% Shareholder
AVEO
AVEO PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
IONQ
IonQ, Inc. Technology
> 10% Shareholder
AKUS
Akouos, Inc. Healthcare
> 10% Shareholder
ACLX
Arcellx, Inc. Healthcare
> 10% Shareholder
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
SVRA
Savara Inc Healthcare
> 10% Shareholder
FREQ
Frequency Therapeutics, Inc. Healthcare
MM

Mohamad Makhzoumi

> 10% Shareholder
Menlo Park, CA

Track Institutional and Insider Activities on GLUE

Follow Monte Rosa Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLUE shares.

Notify only if

Insider Trading

Get notified when an Monte Rosa Therapeutics, Inc. insider buys or sells GLUE shares.

Notify only if

News

Receive news related to Monte Rosa Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GLUE